股票 › DMII
美国制药收购公司二号 DMII
美股市值排名 #3522
$10.21 −$0.01 (-0.10%)
休市 · Nov 6, 8:10 pm ET
开盘$10.21
昨收$10.22
当日区间$10.21 – $10.21
成交量70.1K
市值$650.38M
市盈率（TTM）35.0
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$112,227.00-194.8% YoY
净利润$4.40M+11,647.4% YoY
摊薄每股收益$0.07+11,805.7% YoY
自由现金流-$172,746.00-6,551.8% YoY
经营现金流-$172,746.00
营收，近6个季度
净利润，近6个季度
各季度摊薄每股收益
各季度自由现金流
盈利能力与资产负债表
净资产收益率5.3%
资产收益率5.1%
投入资本回报率1.9%
流动比率0.34
负债/资产比率3.5%
现金及投资$174,974.00
总负债$450,000.00
净现金（净负债）-$275,026.00
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 ANNUAL | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$172,746.00 | -$102,503.00 | -$314,864.00 | -$1.02M | -$690,726.00 |
| 营运资金变动 | -$60,519.00 | $29,527.00 | -$79,391.00 | -$607,645.00 | -$565,821.00 |
| 持续经营经营活动现金流净额 | -$172,746.00 | -$102,503.00 | -$314,864.00 | -$1.02M | -$690,726.00 |
| 持续经营净利润 | $4.40M | $4.34M | $4.33M | $4.19M | -$46,158.00 |
| 期初现金余额 | $347,720.00 | $223.00 | $315,087.00 | $17,035.00 | $4,394.00 |
| 自由现金流 | -$172,746.00 | -$102,503.00 | -$314,864.00 | -$1.02M | -$690,726.00 |
| 现金净变动 | -$172,746.00 | $347,497.00 | -$314,864.00 | -$16,812.00 | $310,693.00 |
| 期末现金余额 | $174,974.00 | $347,720.00 | $223.00 | $223.00 | $315,087.00 |
| 债务发行及偿还净额 | $0.00 | $450,000.00 | $0.00 | -$533,781.00 | -$533,781.00 |
| 其他非现金项目 | -$4.51M | -$4.44M | -$4.82M | -$4.86M | -$78,747.00 |
| -应收款变动 | $0.00 | $30,000.00 | -$245,844.00 | -$812,113.00 | -$563,673.00 |
| -预付资产变动 | -$38,808.00 | $21,773.00 | -$10,814.00 | $16,766.00 | -$10,420.00 |
| -应付账款及应计费用变动 | -$21,711.00 | -$22,246.00 | $177,267.00 | $187,702.00 | $8,272.00 |
| 筹资活动现金流 | $0.00 | $450,000.00 | $0.00 | $501.00M | $501.00M |
| 持续经营筹资活动现金流净额 | $0.00 | $450,000.00 | $0.00 | $501.00M | $501.00M |
| 普通股发行净额 | – | – | $0.00 | $502.00M | – |
| 其他筹资费用净额 | – | – | $0.00 | -$464,800.00 | – |
| 持续经营投资活动现金流净额 | – | – | $0.00 | -$500.00M | – |
| 投资活动现金流净额 | – | – | $0.00 | -$500.00M | – |
| 投资购置及出售净额 | – | – | $0.00 | -$500.00M | – |
| 持续经营损益 | – | – | – | -$553,748.00 | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 ANNUAL | 2025 Q3 |
|---|---|---|---|---|---|
| 负债合计 | $18.14M | $18.17M | $17.80M | $17.80M | $18.18M |
| 流动负债合计 | $644,574.00 | $666,285.00 | $300,864.00 | $300,864.00 | $677,345.00 |
| 应付款 | $12,253.00 | $49,166.00 | $99,359.00 | $99,359.00 | $4,592.00 |
| -应付账款 | $12,253.00 | $49,166.00 | $99,359.00 | $99,359.00 | $4,592.00 |
| 短期债务及融资租赁负债 | $450,000.00 | $450,000.00 | – | – | – |
| -一年内到期债务 | $450,000.00 | $450,000.00 | – | – | – |
| 非流动负债合计 | $17.50M | $17.50M | $17.50M | $17.50M | $17.50M |
| 长期应付账款及其他应付款 | $17.50M | $17.50M | $17.50M | $17.50M | $17.50M |
| 其他非流动资产 | $513.88M | $509.37M | $504.93M | $504.93M | $500.11M |
| 非流动资产合计 | $513.88M | $509.37M | $504.93M | $504.93M | $500.11M |
| 总资产 | $514.10M | $509.73M | $504.96M | $504.96M | $501.01M |
| 流动资产合计 | $217,823.00 | $351,761.00 | $26,037.00 | $26,037.00 | $896,356.00 |
| 现金及现金等价物与短期投资 | $174,974.00 | $347,720.00 | $223.00 | $223.00 | $315,087.00 |
| -现金及现金等价物 | $174,974.00 | $347,720.00 | $223.00 | $223.00 | $315,087.00 |
| 应收款 | $0.00 | $0.00 | $0.00 | $0.00 | $566,269.00 |
| -一年内应收关联方款项 | $0.00 | $0.00 | $0.00 | $0.00 | $566,269.00 |
| 预付资产 | $42,849.00 | $4,041.00 | $25,814.00 | $25,814.00 | $15,000.00 |
| 股东权益合计 | $495.96M | $491.56M | $487.16M | $487.16M | $482.83M |
| 股东权益 | $495.96M | $491.56M | $487.16M | $487.16M | $482.83M |
| 股本 | $513.88M | $509.38M | $504.94M | $504.94M | $500.11M |
| -普通股 | $513.88M | $509.38M | $504.94M | $504.94M | $500.11M |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 留存收益 | -$17.93M | -$17.82M | -$17.78M | -$17.78M | -$17.28M |
| 一年内应计费用 | $182,321.00 | $167,119.00 | $201,505.00 | $201,505.00 | $119,005.00 |
| 一年以上递延资产 | – | – | $0.00 | $0.00 | $0.00 |
| 其他流动负债 | – | – | – | – | $553,748.00 |
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 ANNUAL | 2025 Q3 |
|---|---|---|---|---|---|
| 税前利润 | $4.40M | $4.34M | $4.33M | $4.19M | -$46,158.00 |
| 特殊收益（费用） | $0.00 | – | – | $553,748.00 | – |
| 非经营性利息收入 | $4.51M | $4.44M | $4.82M | $4.93M | $109,355.00 |
| 非经营性利息净收入（支出） | $4.51M | $4.44M | $4.82M | $4.93M | $109,355.00 |
| 营业利润 | -$112,227.00 | -$102,030.00 | -$1.05M | -$1.30M | -$155,513.00 |
| -管理费用 | $112,227.00 | $132,030.00 | $235,472.00 | $488,385.00 | $155,513.00 |
| 销售及管理费用 | $112,227.00 | $132,030.00 | $235,472.00 | $488,385.00 | $155,513.00 |
| 营业费用 | $112,227.00 | $102,030.00 | $1.05M | $1.30M | $155,513.00 |
| 净利润 | $4.40M | $4.34M | $4.33M | $4.19M | -$46,158.00 |
| 归属母公司净利润 | $4.40M | $4.34M | $4.33M | $4.19M | -$46,158.00 |
| 摊薄每股收益 | $0.07 | $0.07 | $0.16 | $0.15 | $0.00 |
| 基本每股收益 | $0.07 | $0.07 | $0.17 | $0.16 | $0.00 |
| 归属普通股股东净利润 | $4.40M | $4.34M | $4.33M | $4.19M | -$46,158.00 |
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 持续经营利润 | $4.40M | $4.34M | $4.33M | $4.19M | -$46,158.00 |
| 资产减值损失 | – | -$30,000.00 | – | $812,113.00 | – |
| -减：其他特殊支出 | – | – | – | -$553,748.00 | – |
| 其他收入（支出） | – | – | – | $553,748.00 | – |
暂无评论——快来第一个聊聊 DMII。
登录后参与讨论。